Clinical Trials

48 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT05005299 2023-08-01

VICTORY

LymphoidMyeloidOther hematologic neoplasmPlasma cell

18 enrolled

Graft vs Host Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05970822 2023-08-01

Study of BC3402 in Combination With Azacitidine in Patients With MDS and CMML

32 enrolled

Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

NCT05140811 2023-05-24

A Study of IMM01 Combined With Azacitidine in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome

126 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT05823714 2023-04-21

Venetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Myeloid Leukemia and Myelodysplastic Syndromes Undergoing Allo-HSCT

70 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT05448599 2023-03-15

A Clinical Study of 6MW3211 Monotherapy or Combination Therapy for AML or MDS

120 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT04226768 2022-10-04

Enhanced Palliative Care in MDS and AML

Phase NA Unknown

90 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT05426798 2022-06-22

Clinical Study of TQB2618 Injection in Combination With Demethylation Drugs in Patients With Recurrent/Refractory Acute Myeloid Leukemia, Myelodysplastic Syndromes

73 enrolled

Myelodysplastic Syndromes, Recurrence, Leukemia, Myeloid, Acute

NCT04764513 2022-03-28

Safety and Efficiency of γδ T Cell Against Hematological Malignancies After Allo-HSCT

Lymphoma, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05175508 2022-01-03

Aza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDS

Phase 2/3 Unknown

180 enrolled

Frailty, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT05066958 2021-10-04

Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Virus Diseases, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05061147 2021-10-01

A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of Max-40279-01 in Combination With Azacitidine (AZA) in Patients With Myelodysplastic Syndrome (MDS) or Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)

100 enrolled

Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT04370457 2021-08-04

MyPal ePRO-based Early Palliative Care System in Adult Patients With Hematologic Malignancies

Phase NA Unknown

300 enrolled

Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell

NCT04429191 2021-06-11

JSP191 Antibody Conditioning Regimen in MDS/AML Subjects Undergoing Allogenic Hematopoietic Stem Cell Transplantation

Classical hematologyMyeloidOther hematologic neoplasm

40 enrolled

Anemia, Refractory, with Excess of Blasts, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT04906031 2021-06-09

Sodium Stibogluconate in the MDS/AML With One of the 65 Defined p53 Mutations

5 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT01894477 2021-06-03

Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia

102 enrolled 12 charts

Phase EARLY_PHASE1 Unknown

Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Neoplasm, Residual, Myelodysplastic-Myeloproliferative Diseases

NCT03795779 2021-05-19

CLL1-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic Malignancies

Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT02124174 2021-04-26

Vidaza and Valproic Acid Post Allogeneic Transplant for High Risk AML and MDS

Classical hematologyMyeloidOther hematologic neoplasm

50 enrolled

Anemia, Refractory, with Excess of Blasts, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT03800095 2021-03-24

CALVI

Phase 3 Unknown

140 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Lymphoma, Large B-Cell, Diffuse, Hematologic Neoplasms

NCT03083054 2020-10-12

Cellular Immunotherapy for Patients With High Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia

5 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT02856464 2020-04-02

PRO-DLI

124 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT01619761 2020-02-11

NK Cells in Cord Blood Transplantation

13 enrolled

Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02272478 2020-01-23

AML18

Phase 2/3 Unknown

1,600 enrolled

Phase EARLY_PHASE1 Unknown

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT04156256 2019-11-12

CD123-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic Malignancies

Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT03836690 2019-10-25

ToTem

Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

18 enrolled

Primary Immunodeficiency Diseases, Anemia, Aplastic, Graft vs Host Disease, Leukemia, Lymphoma, Myelodysplastic Syndromes, Neoplasms, Plasma Cell

NCT01211457 2019-07-16

Study of Sapacitabine in Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS)

65 enrolled

Myelodysplastic Syndromes, Recurrence, Leukemia, Myeloid, Acute

NCT03978364 2019-06-07

A Study of Azacitidine for Patients With Int/High -Risk MDS and AML-MRC

Phase 3 Unknown

100 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT01240525 2019-02-12

ProT4

LymphoidMyeloidOther hematologic neoplasmPlasma cell

114 enrolled

Bronchiolitis Obliterans Syndrome, Graft vs Host Disease, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Leukemia, Myelomonocytic, Juvenile

NCT03454984 2018-11-15

SGI-110 and Donor Lymphocyte Infusions (DLI) After Allogeneic Stem Cell Transplantation

40 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT02717884 2018-10-18

TRANSATRA

60 enrolled

Myelodysplastic Syndromes, Recurrence, Leukemia, Myeloid, Acute

NCT03655145 2018-08-31

MacHaploMud

Phase 3 Unknown

344 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03235973 2018-06-28

CEREAL

29 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02576301 2018-06-04

AML

105 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT01451268 2018-03-20

PANOBEST

62 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT03091933 2017-12-06

GLIDE